Rumors are swirling, if not accurate, that Hydrocision is no longer the Hydrocision we've come to know and love. It has been reported that the company, and whatever technology remains, was acquired by an outside group of investors. What is more troubling is the fact that this transaction lacked the pomp and circumstance that many in the industry anticipated. Seems like the well must have finally dried up for a once promising product. If true, TSB wonders how bad was the multiple on a company that probably generated $3-$5 million in sales, and TSB is being generous with those figures. And that my friends is revenue after five years.
In all likelihood, it was a fire sale. Fire sales are usually preceded by constant turnover in management, downsizing, a lack of operating capital, and lack of direction. Just look at the website, there really hasn't been any activity or maintenance on their site since 2009. The patient lingered for many years battling financial, clinical, and reimbursement issues. Maybe there will be some lessons learned, but then again, that would be wishful thinking. As Einstein once said, the definition of insanity is doing the same thing over and over while expecting different results. If the Board was providing oversight, it should return its Board Fees. Sometimes it makes you wonder.
"Are you happy, are you satisfied, How long can you stand the heat, Out of the doorway the bullets rip, to the sound of the beat,.....Another one bites the dust, Another one bites the dust."